Akin Gump Advises BioPharma Credit PLC and Subsidiaries in $300 Million LumiraDx Financing

April 13, 2021

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Scott Wasserman

Senior Media Relations Manager

(New York) – LumiraDx announced it has secured new financing commitments totaling $400 million, with $300 million of the financing to come from BioPharma Credit PLC and its subsidiaries, which were advised by a team from Akin Gump.

The Akin Gump team advising BioPharma Credit and its subsidiaries was led by tax partner Geoffrey Secol. He was joined by corporate partners Mark Mansell and Shar Ahmed and associates Chloe Abbott and Shane Copelin; tax associate Mohammed Natha; health care and life sciences senior counsel Jo-Ellyn Sakowitz Klein and counsel Marlee Gallant; and international trade partner Nnedinma Ifudu Nweke.

Founded in 1945, Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

# # #

Share This Insight

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.